Research Solutions, Inc. (RSSS) AI Stock Analysis

Research Solutions, Inc. operates as a provider of cloud-based software-as-a-service research platforms and transactional sales of scientific, technical, and medical (STM) content. The company's primary focus is to facilitate accelerated research and development activities for life science and other research-intensive organizations. Through its proprietary Transactions platform, Research Solutions manages the sourcing and delivery of STM articles critical to the intellectual property development lifecycle. Formerly known as Derycz Scientific, Inc., the company rebranded in 2013 and is headquartered in Henderson, Nevada, leveraging its technological infrastructure to streamline access to STM content.

Over a 5-year period from FY2021 to FY2026, revenue grew at an 8.8% CAGR, rising from $32.9M in FY2022 to $49.1M in FY2025 before declining 1.5% to $48.3M in FY2026. Despite the top-line contraction in FY2026, gross margin expanded from 36.5% in FY2022 to 51.9% in FY2026. Operating margin improved from -5.0% in FY2022 to 7.5% in FY2026, and net income reached $2.8M with an EPS of $0.10. For the trailing twelve months, revenue was $48.3M with an operating margin of 7.0%. In the latest quarter ending June 30, 2026, quarterly revenue fell 2.9% year-over-year, while quarterly earnings declined 72.4%.

As of June 30, 2026, Research Solutions held $12.6M in cash and short-term investments, against total assets of $45.7M and shareholders' equity of $20.7M. The company reported a current ratio of 0.83. Operating cash flow stood at $5.3M in FY2026, supporting free cash flow of $5.2M. Cash utilization in FY2026 included capital expenditures of $39,771 and share buybacks of $53,039. Over the past 5 years, the company's share count increased 20.3%.

At a last close of $2.00 on October 16, 2026, Research Solutions has a market capitalization of $67.5M and an enterprise value of $58.3M. The stock trades at a trailing P/E of 22.2x and a forward P/E of 16.2x, below the median of its US-listed Technology peers at 28.1x and 18.8x, respectively. Its price-to-sales of 1.4x and EV-to-EBITDA of 15.1x also sit below peer medians of 2.8x and 16.6x. Over the past year, the stock fell 38.5%, trailing the S&P 500 (SPY) return of 16.8%.

Wall Street coverage reflects 2 Strong Buy ratings, 1 Buy rating, and no Hold, Sell, or Strong Sell ratings. The mean price target is $3.83, which is 91.7% above the last close of $2.00. For the fiscal year ending June 30, 2027, consensus estimates project revenue of $49.0M and EPS of $0.14. Over the last 4 quarters, the company registered 0 EPS beats. The next earnings date is scheduled for November 12, 2026.

This page is an AI-written research summary of Research Solutions, Inc. (RSSS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: RSSS income statement, RSSS balance sheet, RSSS key metrics, RSSS analyst forecast, RSSS chart. See the RSSS stock overview for the latest quote and news.